Journal of Cancer Therapy
Vol.5 No.3(2014), Paper ID 44115, 16
pages
DOI:10.4236/jct.2014.53035
Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer
Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Makoto Ikenoue, Yukie Shirasaki, Kunihide Nakamura
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Copyright © 2014 Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Makoto Ikenoue, Yukie Shirasaki, Kunihide Nakamura et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Ayabe, T. , Tomita, M. , Chosa, E. , Ikenoue, M. , Shirasaki, Y. and Nakamura, K. (2014) Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer.
Journal of Cancer Therapy,
5, 281-296. doi:
10.4236/jct.2014.53035.